Poland Cardiac Surgery Instruments Market Report 2022 to 2030

Poland Cardiac Surgery Instruments Market Analysis

$ 3999

The Poland Cardiac Surgery Instruments Market is expected to witness growth from $12 Mn in 2022 to $21 Mn in 2030 with a CAGR of 7.05% for the forecasted year 2022-2030. Cardiovascular diseases are becoming more prevalent in Poland as the country's populace increases. Additionally, the older population has more complicated health problems, which increases the demand for cardiac surgery instruments in Poland. The market is segmented by type, application and by end user. Some key players in this market include Metrum Cryoflex, Skamex, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.

ID: IN10PLMD004 CATEGORY: Medical Devices GEOGRAPHY: Poland AUTHOR: Jigyasu Bhandari

Buy Now

Poland Cardiac Surgery Instruments Healthcare Market Executive Analysis

The Poland Cardiac Surgery Instruments Market size is at around $12 Mn in 2022 and is projected to reach $21 Mn in 2030, exhibiting a CAGR of 7.05% during the forecast period. In the EU, Poland has some of the lowest health spendings. (EU). Poland's 2020 health spending per person is $1347.23, or 6.3% of GDP, compared to the EU average of $3000, or 10.12% of GDP. Public funding only covers 72% of expenses, which is less than the EU average of 79%. The relatively expensive out-of-pocket expense (22%) raises accessibility concerns. Despite a drop from 23% in 2014 to 19% in 2023, Poland still has a greater prevalence of daily smokers among adults than the majority of other European Union (EU) nations.

Poland has a high incidence and prevalence of cardiovascular diseases, which are a major cause of death there. 45.3% of all fatalities in Poland in 2020 were caused by cardiovascular diseases. Over 20% of all deaths in Poland are caused by ischemic heart disease, making it the country's highest mortality. It results from diminished blood flow to the heart as a result of clogged or narrowed blood vessels. In Poland, heart failure affects 2% of the population and is a frequent cardiovascular illness complication. It results from the heart's ineffective blood pumping. In cardiac surgery, specialized medical instruments are employed to gain access to, view, manipulate, and repair the heart and blood vessels. These tools are crucial for cardiac surgery because they let medical professionals carry out intricate operations with accuracy and precision.

During coronary artery bypass grafting operations, blood is redirected around heart arteries that are blocked or constrained using cardiac surgical equipment. This treatment is used to address severe coronary artery disease. Instruments used in cardiac surgery are used during operations to replace or repair damaged heart valves. Cardiac surgery instruments are used to take out the injured valve and replace it with a prosthetic valve. In order to give surgeons, the precision and accuracy they need to perform procedures with a reduced risk of complications and better patient outcomes, instruments for cardiac surgery are developed. It has been demonstrated that using cardiac surgery tools can shorten operating times, which could result in faster healing and shorter hospital stays. Instruments used in cardiac surgery are sterilized before use to lower the chance of infection during procedures. It has been demonstrated that using cardiac surgery instruments improves patient outcomes by lowering the possibility of complications and increasing the probability that surgical operations will be successful.

Poland Cardiac Surgery Instruments Market Analysis

Market Dynamics

Market Growth Drivers

Poland's expanding population is contributing to a rise in the prevalence of cardiovascular diseases there. Additionally, older people tend to have more complex health issues, which raises the demand for cardiac surgery tools in the Polish market. In Poland, ischemic and rheumatic heart disease are noticeably more frequent. The nation's need for cardiac surgery tools is anticipated to increase due to the increasing prevalence of these diseases. Particularly for cardiac operations, Poland's reputation as a medical tourism location is growing quickly. The nation's need for top-notch cardiac surgery instruments is expected to grow as a result. Poland recently made investments in new clinics, hospitals, and other healthcare facilities, which increases the demand for cardiac surgery instruments in Poland's healthcare market.

Market Restraints

Poland's relatively small populace and access to complementary therapies may limit the market for cardiac surgery equipment there. Because of this, it might be difficult for manufacturers to attain economies of scale, which might limit their potential for growth. Making instruments for cardiac surgery can be costly because Poland uses cutting-edge materials and technologies. As a result, it might be difficult for producers to compete on price, especially if imports from other countries are available at lower prices.

Competitive Landscape

Key Players

Metrum Cryoflex (PL)
Skamex (PL)
LivaNova
B. Braun
KLS Martin
Medline Industries
STILLE

Recent Notable Deals

2022: The German medical device business Raumedic sold its portfolio of cardiac surgery and vascular surgery to the Polish medical device company Adamed Group in 2022.

Healthcare Policies and Regulatory Landscape

The Medical Devices Act in Poland lays out the regulations for the production, use, and distribution of tools used in cardiac surgery. According to the act, cardiac surgery equipment must adhere to all applicable EU laws, including the Medical Device Regulation (MDR) and the In-Vitro Diagnostic Medical Devices Regulation (IVDR), which specify standards for performance, quality, and safety. All medical devices distributed in the EU must bear the CE marking, including equipment used in cardiac surgery. The marking serves as proof that the device complies with all applicable EU standards and laws. In Poland, the National Health Fund (NFZ) is in charge of paying for medical treatments, equipment, and supplies like tools used in cardiac surgery. The Ministry of Health sets reimbursement policies, which are based on how cost-effective the treatment or device is. Medical equipment clinical studies must adhere to the Clinical studies Regulation of the EU and be approved by the Ministry of Health. This includes cardiac surgery instruments. Strict ethical and safety guidelines must be followed during the studies.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Cardiac Surgery Instruments Market Segmentation

By Type (Revenue, USD Billion):

The market is divided into segments in this study based on the goods, applications, end users, and geographical areas. The market is divided into forceps, scissors, needle holders, clamps, and other cardiac surgery instruments based on the product. In 2017 the forceps category led the market, and it is anticipated that it will increase at the fastest rate going forward. The rise in heart surgeries and the frequent usage of forceps in most cardiac procedures are credited with the segment's strong growth.

Forceps
Vascular Forceps
Grasping Forceps
Other Forceps
Needle Holders
Scissors
Clamps
Other Cardiac Surgical Instruments

By Application (Revenue, USD Billion):

The market is further segmented by application into paediatric cardiac surgery, heart valve surgery, coronary artery bypass graft (CABG), and other applications. The Poland market's largest and fastest-growing application segment is CABG. This is mostly explained by the increased prevalence of heart illnesses and the consequent rise in surgical treatments. The second-largest category is heart valve surgery.

Coronary Artery Bypass Graft (CABG)
Heart Valve Surgery
Pediatric Cardiac Surgery
Other Applications

By End User (Revenue, USD Billion):

Based on the end user, the market is segmented into hospitals and cardiac centers, and ambulatory surgery centers. The hospitals and cardiac centers segment is expected to dominate the market for cardiac surgery instruments. Growth in this end-user segment can be attributed to the increasing incidence of cardiac and heart valve diseases and the subsequent increase in the number of cardiac surgery procedures.

Hospitals and Cardiac Centers
Ambulatory Surgery Centers

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.